1. Home
  2. CNVS vs XLO Comparison

CNVS vs XLO Comparison

Compare CNVS & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cineverse Corp.

CNVS

Cineverse Corp.

HOLD

Current Price

$2.69

Market Cap

56.4M

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$9.44

Market Cap

56.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNVS
XLO
Founded
2000
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.4M
56.9M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
CNVS
XLO
Price
$2.69
$9.44
Analyst Decision
Buy
Buy
Analyst Count
1
1
Target Price
$9.00
$28.00
AVG Volume (30 Days)
110.0K
17.2K
Earning Date
02-17-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$65,733,000.00
$43,766,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$84.42
$168.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
589.88
52 Week Low
$1.77
$0.46
52 Week High
$5.43
$9.90

Technical Indicators

Market Signals
Indicator
CNVS
XLO
Relative Strength Index (RSI) 48.87 61.27
Support Level $2.33 $7.47
Resistance Level $3.37 $9.75
Average True Range (ATR) 0.19 0.42
MACD 0.01 0.03
Stochastic Oscillator 47.88 62.98

Price Performance

Historical Comparison
CNVS
XLO

About CNVS Cineverse Corp.

Cineverse Corp is a technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, and audio podcasts, Podcast, Media services, and Other non-recurring. Its brands include Hallmark, ITV, Nelvana, ZDF, Konami, NFL, and Highlander.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: